title: No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behçet's disease.
abstract: Behçet's disease (BD) is a multisystem inflammatory disorder of unknown etiology, and infections with different microorganisms including streptococci have been claimed as triggers of inflammatory attacks in BD pathogenesis. Toll-like receptor 2 (TLR2) has been known to recognize several microbial antigens including that of streptococci, and TLR2 gene Arg753Gln polymorphism has been reported to be strongly associated with acute rheumatic fever with an odds ratio of 100. This study aimed to investigate the TLR2 gene Arg753Gln polymorphism in a group of patients with BD and rheumatic heart disease (RHD) and to analyze the role of genotyping errors resulting from duplicated gene segments. The study group consisted of 211 patients with BD, 95 patients with RHD, and 94 matched Turkish healthy controls. Because of the duplicated exon 3 in 23-kb upstream of the TLR2 gene, genotyping for the Arg753Gln polymorphism with polymerase chain reaction-restriction fragment length polymorphism method was carried out using a new set of primers and PstI restriction enzyme. TLR2 gene Gln753 allele was observed in two of 211 (1.0%) patients with BD, five of 95 (5.3%) patients with RHD, and two of 94 (2.1%) healthy controls. All patients and controls were found to be heterozygous for Arg753Gln polymorphism, except one patient with BD, who was homozygous for Gln753. Although a slight increase of heterozygosity was noted in patients with RHD, no statistically significant difference was observed in the distribution of Arg753Gln polymorphism in BD and RHD compared to healthy controls. In conclusion, TLR2 gene Arg753Gln polymorphism is not associated with BD nor with RHD; and a duplicated region of the TLR2 exon 3 located 23-kb upstream of the polymorphic region may explain contradictory association findings described so far.
authors.affiliation: Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey.
authors.forename: Fulya
authors.initials: F
authors.lastname: Coşan
authors.forename: Başar
authors.initials: B
authors.lastname: Oku
authors.forename: Aris
authors.initials: A
authors.lastname: Cakiris
authors.forename: Julide
authors.initials: J
authors.lastname: Duymaz-Tozkir
authors.forename: Fehmi
authors.initials: F
authors.lastname: Mercanoğlu
authors.forename: Güher
authors.initials: G
authors.lastname: Saruhan-Direskeneli
authors.forename: Duran
authors.initials: D
authors.lastname: Ustek
authors.forename: Ahmet
authors.initials: A
authors.lastname: Gül
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000175:diagnosis / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D012214:Rheumatic Heart Disease / Q000175:diagnosis / Q000235:genetics*; D051195:Toll-Like Receptor 2 / Q000235:genetics*
chemical_list: C495342:TLR2 protein, human; D051195:Toll-Like Receptor 2
references.citation: Eur Respir J. 2004 Feb;23(2):219-23
references.pmid: 14979495
references.citation: Cell Immunol. 1992 Apr;140(2):410-9
references.pmid: 1544169
references.citation: Eur J Dermatol. 2008 Sep-Oct;18(5):489-98
references.pmid: 18693149
references.citation: FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):125-31
references.pmid: 15681141
references.citation: Hum Genet. 2005 Apr;116(5):413-5
references.pmid: 15726416
references.citation: Clin Exp Dermatol. 2006 Sep;31(5):699-701
references.pmid: 16901312
references.citation: Lancet. 1990 May 5;335(8697):1078-80
references.pmid: 1970380
references.citation: Scand J Infect Dis. 2003;35(9):632-41
references.pmid: 14620147
references.citation: Immunol Lett. 2006 Feb 15;102(2):202-14
references.pmid: 16242782
references.citation: Cytokine. 2002 Oct 21;20(2):56-62
references.pmid: 12445799
references.citation: Clin Rheumatol. 2007 Jun;26(6):915-9
references.pmid: 17096074
references.citation: Clin Exp Rheumatol. 2001 Sep-Oct;19(5  Suppl 24):S6-12
references.pmid: 11760403
references.citation: J Mol Med (Berl). 2005 Jul;83(7):535-41
references.pmid: 15968536
references.citation: J Rheumatol. 1988 Jun;15(6):1029-30
references.pmid: 3418627
references.citation: Hum Immunol. 2009 Jan;70(1):41-4
references.pmid: 19014987
references.citation: J Immunol. 2004 Mar 1;172(5):2739-43
references.pmid: 14978071
references.citation: J Invest Dermatol. 2006 Jul;126(7):1534-40
references.pmid: 16514412
references.citation: Infect Immun. 2000 Nov;68(11):6398-401
references.pmid: 11035751
references.citation: Ocul Immunol Inflamm. 1998 Sep;6(3):139-44
references.pmid: 9785603